https://lipidbank.jp/mediawiki/index.php?action=history&feed=atom&title=LBF20207PG67 2026-04-30T17:17:39Z Revision history for this page on the wiki MediaWiki 1.43.0 https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG67&diff=53128&oldid=prev 2010-10-21T08:45:37Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 17:45, 21 October 2010</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td> <td colspan="2" class="diff-lineno">Line 6:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1747</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidBank=XPR1747</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010065</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|LipidMaps=LMFA03010065</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>|SysName= 9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (5-<del style="font-weight: bold; text-decoration: none;">cis,</del>13<del style="font-weight: bold; text-decoration: none;">-trans</del>) -dien-1-oic acid</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>|SysName=9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (<ins style="font-weight: bold; text-decoration: none;">cis-</ins>5<ins style="font-weight: bold; text-decoration: none;">,trans</ins>-13) -dien-1-oic acid</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;16,16-dimethyl Prostaglandin E_2&amp;&amp;9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (5Z,13E) -dien-1-oic acid&amp;&amp;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Common Name=&amp;&amp;16,16-dimethyl Prostaglandin E_2&amp;&amp;9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (5Z,13E) -dien-1-oic acid&amp;&amp;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|Source=</div></td></tr> <!-- diff cache key wikidb:diff:1.41:old-53127:rev-53128:php=table --> </table>

Editor https://lipidbank.jp/mediawiki/index.php?title=LBF20207PG67&diff=53127&oldid=prev 2010-09-16T01:45:10Z

<p>New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1747 |LipidMaps=LMFA03010065 |SysName= 9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (5-cis,13-trans) -die...</p> <p><b>New page</b></p><div>{{Lipid/Header}}<br /> <br /> {{Hierarchy|{{PAGENAME}}}}<br /> <br /> {{Metabolite<br /> |LipidBank=XPR1747<br /> |LipidMaps=LMFA03010065<br /> |SysName= 9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (5-cis,13-trans) -dien-1-oic acid<br /> |Common Name=&amp;&amp;16,16-dimethyl Prostaglandin E_2&amp;&amp;9-Oxo- (11alpha,15R) -dihydroxy-16,16-dimethyl-prosta- (5Z,13E) -dien-1-oic acid&amp;&amp;<br /> |Source=<br /> |Chemical Synthesis=<br /> |Metabolism=<br /> |Biological Activity= 16,16-dimethyl Prostaglandin E2 shows cervical ripening and uterine constriction and consequent inhibition of ulcer formation.[[Reference:Robert_A:Schultz_JR:Nezamis_JE:Lancaster_C:,Gastroenterology,1976,70,359|{{RelationTable/GetFirstAuthor|Reference:Robert_A:Schultz_JR:Nezamis_JE:Lancaster_C:,Gastroenterology,1976,70,359}}]][[Reference:Coleman_RA:Smith_WL:Narumiya_S:,Pharmacol. Rev.,1994,46,205|{{RelationTable/GetFirstAuthor|Reference:Coleman_RA:Smith_WL:Narumiya_S:,Pharmacol. Rev.,1994,46,205}}]] 16,16-dimethyl Prostaglandin E2 increases eNOS mRNA expression of adult microvessels to values in the newborn pig.[[Reference:Dumont_I:Hou_X:Hardy_P:Peri_KG:Beauchamp_M:Najarian_T:Molotchnikoff_S:Varma_DR:Chemtob_S:,J. Pharmacol. Exp. Ther.,1999,291,627|{{RelationTable/GetFirstAuthor|Reference:Dumont_I:Hou_X:Hardy_P:Peri_KG:Beauchamp_M:Najarian_T:Molotchnikoff_S:Varma_DR:Chemtob_S:,J. Pharmacol. Exp. Ther.,1999,291,627}}]] 16,16-dimethyl Prostaglandin E2 prevents indomethacin-induced gastric lesions.[[Reference:Suzuki_K:Araki_H:Komoike_Y:Takeuchi_K:,Med. Sci. Monit.,2000,6,908|{{RelationTable/GetFirstAuthor|Reference:Suzuki_K:Araki_H:Komoike_Y:Takeuchi_K:,Med. Sci. Monit.,2000,6,908}}]]<br /> }}<br /> <br /> {{Lipid/Footer}}</div>

Editor